That Single Patient: Episode 2

In the second episode of the "That Single Patient" Series, Dr. Catherine van Montfrans sits down with Dr. Ana Maria Forsea to share the story of her first melanoma patient, a young mother with stage IV disease, whose resilience and dignity left a lasting impression. From the clinic to the lab, Ana Maria reflects on the lessons she learned about empathy, presence, and truly seeing the patient beyond the disease. This episode highlights how compassionate communication, time, and human connection can profoundly influence both patient care and a clinician’s professional path.

In this first episode of the "That Single Patient" Series, hosted by Dr. Catherine van Montfrans, Prof. Johannes Ring shares a notable case of a young patient with severe eczema who made remarkable progress during a clinical trial. The episode highlights the vital role of time, care, and hope in patient treatment. Discover how attentive listening and compassionate interaction can profoundly influence patient outcomes in this insightful conversation.

Join Emek Kocatürk as she presents her selection of Editor’s Picks from the October 2025 issue: Microplastics in Practice: Rethinking Dermatology for Planetary Health Erectile Dysfunction in Dermatology: An Overlooked Link in Patient Care Heart Failure Risk with TNFi in Immune-Mediated Diseases: Time to Rethink the Guidelines? Chronic Spontaneous Urticaria in Europe: High Burden, Low Control   Read the Editor's Picks here: https://doi.org/10.1111/jdv.70004

In this episode of the EADV Podcast, host Prof. Carle Paul welcomes Prof. Michel Gilliet, Professor and Chairman of Dermatology at the University of Lausanne and Chair of the EADV Scientific Programming Committee. Together, they explore groundbreaking advancements in skin immunology, with a particular focus on personalised medicine for immune-mediated skin diseases. Prof. Gilliet discusses his pioneering work in pathway profiling, a method designed to identify dominant inflammatory pathways in skin specimens. This personalised approach allows for targeted diagnosis and treatments, improving patient outcomes. They also delve into the practical applications of this technology, its potential to redefine diagnostic precision, and its promise for broader implementation across Europe. Ideal for dermatologists, researchers, and clinicians seeking to stay at the forefront of dermatological innovation, this #EADVPodcast episode uncovers how molecular profiling is paving the way for personalised medicine in dermatology.   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5mFx4sZqS_vQtdTGOGIbwb1   You are invited to participate in our survey to improve the show. Your feedback is valued and appreciated to allow us to better serve our audience: https://eadv.org/eadv-podcast-survey/

Join Professor Carle Paul presenting his selection of Editor’s Picks from the September 2025 issue: European Guidelines for atopic dermatitis: a “step” forward  Delgocitinib for hand eczema: minimal systemic absorption Sodium consumption and increased risk of psoriasis: Stop salty junk food Integration of dermatologists in primary care is cost-effective    Read the Editor's Picks here: https://doi.org/10.1111/jdv.20860   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5m-HkKi3nwSZ0ecsjFp431A      

In this insightful episode of the EADV Podcast, Prof. David de Berker is joined by Dr. Eugene Tan, an academic dermatologist and Mohs micrographic surgeon based in New Zealand, to discuss the environmental and clinical impact of plastics in dermatology. Their discussion, inspired by Dr. Tan’s open-access article “Plastics in Dermatology: A Review and Solutions”, recently published in the JEADV, explores the science behind microplastics and nanoplastics, the life cycle of plastic products in medicine, and practical ways dermatologists and patients can reduce their plastic footprint. Dr. Tan explains how limited but consistent scientific findings raise significant concerns about plastics in skincare, and why sustainability in dermatology requires both individual and systemic action. From the power of consumer choice to international regulation and biodegradable alternatives, this episode offers a broad yet actionable perspective on an urgent issue. Tune in to learn what steps you and your patients can take today to create a more sustainable dermatology practice. Reference: https://onlinelibrary.wiley.com/doi/10.1111/jdv.20537   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5mFx4sZqS_vQtdTGOGIbwb1   You are invited to participate in our survey to improve the show. Your feedback is valued and appreciated to allow us to better serve our audience: https://eadv.org/eadv-podcast-survey/

Join Dr. Rolland Gyulai presenting his selection of Editor’s Picks from the August 2025 issue: Buy one, get one free! Beyond preventing skin cancer, ALA-PDT Treatment rejuvenates the skin  For erythrodermic mycosis fungoides, think methotrexate!  Is the ugly duckling unimportant after all?  Not all patients with hidradenitis suppurativa are created equal   Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.20537   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5m-HkKi3nwSZ0ecsjFp431A    

In this episode of the EADV Podcast, host Dr. Sarah Walsh sits down with Prof. Thrasivoulos Tzellos during the 2025 EADV Spring Symposium in Prague to discuss the latest European guidelines for the treatment of hidradenitis suppurativa (HS). Together, they explore the evolution of HS care, the role of general practitioners in early detection, the value of clinical tools and patient-reported outcomes, and the potential of emerging therapies. Prof. Tzellos also shares his thoughts on antimicrobial resistance, phenotype-based treatment, and the importance of multidisciplinary care. The conversation is grounded in both evidence-based recommendations and real-world clinical experience, with reflections on how advocacy and access to care remain vital components of improving outcomes for HS patients across Europe. Tune in to discover practical insights and the latest developments that are shaping the future of HS treatment. Read the full Guidelines: https://onlinelibrary.wiley.com/doi/10.1111/jdv.20472   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5mFx4sZqS_vQtdTGOGIbwb1

Join Professor Carle Paul presenting his selection of Editor’s Picks from the July 2025 issue: Skin barrier topographic: clues to understand the pathogenesis of immune skin disease Fighting melanoma in Europe: the Icelandic example When to initiate biological agents in psoriasis: does timing really matter? Reactional leukokeratosis of the penis: a new clinical entity Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.20733   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5m-HkKi3nwSZ0ecsjFp431A  

In this special episode of the EADV Podcast, host Dr. Tiago Matos, member of the EADV Advocacy Task Force, is joined by Prof. Myrto Trakatelli, Chair of the EADV Advocacy Task Force and EADV Board Member, for a candid conversation on advocacy in dermatology. They reflect on the recent EADV advocacy event at the European Parliament focused on the health risks of sunbed use. From the interactions with Members of the European Parliament (MEPs), to new legislation in Denmark, this episode highlights how persistent efforts and strategic communication are shifting the policy landscape. Listeners will hear important contributions including a message from EADV President Prof. Branka Marinović, who explains why advocacy is a key part of the Academy’s mission; Astrid Nørlund-De Heer, a melanoma survivor and patient advocate, who shares her powerful story; Dr. Aleksandra Lesiak member of the EADV Advocacy Task Force speaks with MEP Dariusz Joński, who expresses his support for stronger sunbed regulations in Europe. Tune in to hear why sunbed regulations matter, how dermatologists can influence policy, and why advocacy is a crucial pillar of public health in dermatology. In this episode, host Prof. Jan Gutermuth explores with Prof. Christoffer Gebhardt the evolving landscape of melanoma prognosis. Together they discuss current strategies for predicting outcomes in melanoma patients, including clinical staging, histopathological features, and emerging molecular and genetic biomarkers. The conversation highlights how personalised medicine and novel diagnostic tools are shaping prognosis accuracy and guiding treatment decisions. Ideal for dermatologists, oncologists, and researchers, this #EADVPodcast episode underscores the importance of integrating science and patient care to improve long-term survival in melanoma. Passionate about Personalised Medicine? JEADV has an ongoing Call for Papers waiting for your contribution. Visit our website to know more: JEADV Call for papers: Personalised Medicine in Dermatology   Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5mFx4sZqS_vQtdTGOGIbwb1   You are invited to participate in our survey to improve the show. Your feedback is valued and appreciated to allow us to better serve our audience: https://eadv.org/eadv-podcast-survey/